Histone deacetylase inhibitors and a functional potent inhibitory effect on human uterine contractility
Authors:
- Aidan M. SharkeyASAidan M. Sharkey
- John J. MorrisonJMJohn J. Morrison
- 1 August 2008
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 199 (2) , 167.e1-167.e7
Abstract
No abstract availableKeywords
Funding Information
- Health Research Board
- Action Medical Research
This publication has 20 references indexed in Scilit:
- Acetylation in the regulation of metalloproteinase and tissue inhibitor of metalloproteinases gene expressionFrontiers in Bioscience-Landmark, 2007
- Inhibitory effect of leptin on human uterine contractility in vitroAmerican Journal of Obstetrics and Gynecology, 2006
- Histone deacetylase inhibitor trichostatin A inhibits the growth of bladder cancer cells through induction of p21WAF1 and G1 cell cycle arrestInternational Journal of Urology, 2006
- Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancerNature Reviews Cancer, 2006
- Histone deacetylase HDAC8 associates with smooth muscle α‐actin and is essential for smooth muscle cell contractilityThe FASEB Journal, 2005
- Expression of Histone Deacetylase 8, a Class I Histone Deacetylase, Is Restricted to Cells Showing Smooth Muscle Differentiation in Normal Human TissuesThe American Journal of Pathology, 2004
- A Link Between Histone Deacetylase Inhibitors and NF-kappaB SignalingCell Cycle, 2003
- Valproic acid for the treatment of pediatric malignant gliomaKlinische Padiatrie, 1999
- Trichostatin A and trapoxin: Novel chemical probes for the role of histone acetylation in chromatin structure and functionBioEssays, 1995
- Valproic AcidDrugs, 1994